He actually went off to spin up and be director at EMD.asx once EMD.asx was IPO and spun up collecting RWD from special access schemes (again around cannabis products and getting early indicators of other targets) he then popped back over to BOT.
I've been waiting for the EMD + BOT colab announcement ever since. (and again EMD has a director from jazz pharma - who bought GW & epidiolex for 7.5B) so another connection / announcement i have been waiting for a TO from jazz pharma.
All the best Matt to you and family was great hearing your 'long form' interview about your career that came out about a year ago.
BOT Price at posting:
37.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)